-
-
Tues - Fri: Call For Hours
-
1321 Old Oak Place, Montgomery, AL. 36117
-
(334)386-3551
Semaglutide Injection Information
Put simply, medications like Semaglutide, marketed as Wegovy or Ozempic, help to enhance insulin sensitivity. This leads to the burning of calories and fat, along with an improvement in energy levels. Semaglutide is a peptide that functions by mimicking the actions of a hormone known as glucagon-like peptide 1 (GLP-1), which targets a part of the brain responsible for regulating hunger and food consumption. By managing blood sugar levels, curbing spikes, and decreasing cravings and appetite, Semaglutide helps maintain more consistent energy levels. It is administered via a subcutaneous injection, typically given once weekly, with the option to adjust the dosage if necessary after one month.
What Are The Benefits?
Surveys have shown that one out of every three participants achieves a 20% reduction in body weight through the program. Additionally, one out of every two participants experiences a 15% decrease in body weight. On average, Semaglutide by itself can contribute to a weight loss of 2-4 pounds per week.
Advantages include:
Benefit of appetite suppression.
Enhance insulin sensitivity, facilitate fat burning, and increase energy levels.
Experience safety and effectiveness with a once-weekly injection.
There is a high success rate when combined with DWTP medical weight loss programs
FDA approval has been granted for weight loss.
** Semaglutide injections may cause nausea. Please let us know if you experience any nausea and we will prescribe and dispense you nausea medication. **
Semaglutide dosing will begin with 1mg/mL dosing as administered below.
Month 1: Weeks 1-4 injections will be 0.25 mL once weekly
Month 2: Weeks 5-8 injections will be 0.50 mL once weekly
Month 3: Weeks 9-12 injections will be 1.0 mL once weekly
If normal BMI is not acheived after week 12 the dosing will titrate up to 2.4mg/mL.
Month 4: Weeks 13-16 injections will be 0.70 mL once weekly
Month 5: Weeks 17 onward injections will be 0.50 mL once weekly
If normal BMI is not acheived after 17 or more weeks a final maintenance dose will be given of 2.4mg/mL monthly.
Contact With Us
Have Questions?
